Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions
The OVD market is expected to grow slightly throughout the forecast period. Demand for OVDs will be driven by the aging population and the associated need for refractive correction among this demographic. OVD use is directly correlated with IOL sales. In general, growth of the IOL market is driven by the increasing prevalence of cataracts, a condition that is associated with older age. Since standard monofocal IOLs are covered by most government health insurance overall IOL insertion rates do not depend on economic stability. Because of this, procedure rates should remain constant as should OVD use.
Whether a dispersive or cohesive OVD is used depends on both physician preference and the situation; however, both are similarly priced. Combination OVDs are being produced in an attempt to provide the advantages of both cohesive and dispersive OVDs and thus simplifying the procedure. Some physicians however do not see combination OVDs as an improvement and are not willing to pay the more premium price for them. Finally some companies also package an anesthetic mixed in with their OVD to further simplify things. Again, this is another premium that some physicians find unnecessary and would prefer to anesthetize separately.
Longer life expectancy and a shift towards an older average age among the European population will lead to increased incidences of cataracts. Because cataracts can lead to blindness, the surgery is considered essential. The changing demographics of the European population will therefore lead to an increase in the overall sales of IOLs. OVDs are required for IOL insertion surgeries and thus their sales will increase accordingly.
Abstract Ophthalmic viscosurgical devices (OVD) are viscoelastic solutions used in several eye surgeries. They are also referred to as viscoelastic agents. These fluids have had a great influence on both extracapsular and phacoemulsification surgeries and their use has decreased the incidence of corneal edema. The main task of the OVD is protecting the inner side of the cornea during surgery. It accomplishes this by maintaining a deep anterior chamber during anterior segment surgery. This space prevents contact with and possible damage to the endothelial cell layer on the inner side of the cornea and the surrounding ocular tissues. In addition OVDs help to push back the vitreous face in the event of a posterior capsule tear or a rent in the zonules all the while preventing formation of a flat chamber during surgery.
Scope:2013-2023
Our reports have been used by over 10K customers, including:
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
17 pages •
By Euromonitor International
• Jan 2021
Natural increase will be the sole driver of population expansion in the Dominican Republic up to 2040. While ageing will be a key trend, with rapid growth in the elderly and a decline in the younger age groups, the country will remain relatively young as birth rates remain comparatively high. Nevertheless, as population composition alters...
16 pages •
By Euromonitor International
• Dec 2020
Positive net migration will be the key driver of population growth in Singapore in 2019-2040. Ageing, compounded by low birth rates and rising longevity, will remain a key demographic trend which is set to transform the consumer landscape further, as well as placing mounting pressure on state resources. As a densely population city-state with...
17 pages •
By Euromonitor International
• Nov 2020
After peaking in 2024, depopulation will occur in Germany up to 2040 as falling net migration rates are no longer able to mitigate increasingly negative natural change. As birth rates drop and longevity climbs, ageing will accelerate transforming consumer trends and putting additional pressure on state resources. Urbanisation will continue...
The Europe Ultrasonic Sensors Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026). Ultrasonic sensors delivering real-time visual analysis, which capitalizes during the rising examples of complex medical conditions like cardiovascular disease, orthopedic, and cranial nerve disease, which requires non-invasive...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
17 pages •
By Euromonitor International
• Feb 2021
Natural increase will be the sole driver of swift population growth in Pakistan in 2020-2040, as net migration remains negative. Ageing will be quite slow over this timeframe, with the country remaining extremely young in a regional context due to relatively elevated birth rates and low life expectancy. Urbanisation will be swift and the country...
Healthcare
Diabetes
Obesity
Pathology
Chronic Disease
Pakistan
World
Life Expectancy
Net Migration Rate
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.